Mintz advised the underwriters in connection with SAB Biotherapeutics’ $85 million public offering.

Jefferies, UBS Investment Bank, Citigroup, and Barclays acted as joint book-running managers for the offering. Chardan acted as lead manager.

The Mintz capital markets team included William Hicks, John Rudy, Alok Choksi, Hannah Karraker, Gretchen Goyette, Patricia Garza Gonzalez, and Kate McLeod. Ari Feder advised on tax matters, Jenny Chen advised on intellectual property matters, and Joanne Hawana advised on regulatory matters. Members of the Mintz team are based in the Boston, New York, San Diego, and Washington, DC offices.